Bioactive starch-based scaffolds and human adipose stem cells are a good combination for bone tissue engineering

Bone tissue engineering requires materials that support cell growth and differentiation. While silicon's role in bone formation is known, its integration into scaffolds remains underexplored. Prior research has shown that silicon can influence calcium phosphate deposition and cell differentiation. However, the specific impact of silanol groups on stem cell behavior is unclear. No prior work had resolved how dynamic culturing affects scaffold performance. This gap motivated investigation into how silanol-modified scaffolds influence stem cell osteogenesis. Existing studies focus on static conditions, but dynamic systems may offer better outcomes. The need to evaluate both static and dynamic culturing remains unmet. This paper addresses that need by testing silanol-functionalized scaffolds under both conditions.

This study aimed to assess the effect of silanol-functionalized scaffolds on human adipose stem cell osteogenic differentiation. The specific problem is understanding how scaffold chemistry and culturing conditions influence bone formation. Dynamic culturing may improve cell distribution and proliferation. The motivation stems from the need for reliable, cost-effective bone tissue engineering materials. Silicon's known role in bone formation guided the functionalization approach. The goal was to compare static and dynamic culturing effects. The study also sought to evaluate the practicality of scaffold production methods. By combining silanol groups with a starch-polycaprolactone blend, the researchers aimed to develop a functionalized scaffold.

The researchers created three-dimensional fiber mesh scaffolds using a wet-spinning technique. The blend of corn starch and polycaprolactone was used at a 30/70 weight ratio. A calcium silicate solution served as a non-solvent to introduce silanol groups. The scaffolds were either functionalized with Si-OH groups or left unmodified. Human adipose stem cells were cultured on these scaffolds under two conditions: static and dynamic. Dynamic culturing used a flow perfusion bioreactor to simulate physiological conditions. The cells were tested in either α-MEM or osteogenic medium. The in vitro assessment focused on cell proliferation and osteogenic differentiation markers. The study also evaluated mineralization nodule formation as a differentiation indicator.

Functionalized scaffolds with silanol groups supported cell proliferation and osteogenic differentiation. Cells cultured on SPCL-Si scaffolds formed mineralization nodules, indicating bone formation. Dynamic culturing enhanced cell proliferation compared to static conditions. The flow perfusion bioreactor improved cell distribution within the scaffold structure. The functionalized scaffolds showed better osteogenic potential than non-functionalized ones. Culturing in osteogenic medium increased differentiation markers compared to α-MEM. The SPCL-Si scaffolds maintained structural integrity while supporting cell growth. These results suggest that silanol groups and dynamic culturing are beneficial for bone tissue engineering.

The study supports the use of silanol-functionalized scaffolds for bone tissue engineering. The functionalized scaffolds sustained cell proliferation and induced osteogenic differentiation. Dynamic culturing improved cell distribution and proliferation outcomes. The formation of mineralization nodules indicates successful differentiation. The production process is described as simple and economically viable. These findings suggest that the SPCL-Si scaffolds are promising for future applications. The combination of silanol groups and dynamic culturing enhances scaffold performance. The authors propose that these materials could be used in clinical settings for bone regeneration.